Taking T-Cell Oncotherapy Off-the-Shelf.
Sign Up to like & getrecommendations! Published in 2021 at "Trends in immunology"
DOI: 10.1016/j.it.2021.01.004
Abstract: Banked allogeneic or 'off-the-shelf' (OTS) T cells from healthy human donors are being developed to address the limitations of autologous cell therapies. Potential challenges of OTS T cell therapies are associated with their allogeneic origin… read more here.
Keywords: cell therapies; cell oncotherapy; ots cells; taking cell ... See more keywords